Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta-Analysis

VW. Chan, WS. Tan, A. Asif, A. Ng, O. Gbolahan, E. Dinneen, W. To, H. Kadhim, M. Premchand, O. Burton, JS. Koe, N. Wang, JJ. Leow, G. Giannarini, N. Vasdev, SF. Shariat, D. Enikeev, CF. Ng, JY. Teoh

. 2021 ; 13 (13) : . [pub] 20210630

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024472

External factors, such as the coronavirus disease 2019 (COVID-19), can lead to cancellations and backlogs of cancer surgeries. The effects of these delays are unclear. This study summarised the evidence surrounding expectant management, delay radical prostatectomy (RP), and neoadjuvant hormone therapy (NHT) compared to immediate RP. MEDLINE and EMBASE was searched for randomised controlled trials (RCTs) and non-randomised controlled studies pertaining to the review question. Risks of biases (RoB) were evaluated using the RoB 2.0 tool and the Newcastle-Ottawa Scale. A total of 57 studies were included. Meta-analysis of four RCTs found overall survival and cancer-specific survival were significantly worsened amongst intermediate-risk patients undergoing active monitoring, observation, or watchful waiting but not in low- and high-risk patients. Evidence from 33 observational studies comparing delayed RP and immediate RP is contradictory. However, conservative estimates of delays over 5 months, 4 months, and 30 days for low-risk, intermediate-risk, and high-risk patients, respectively, have been associated with significantly worse pathological and oncological outcomes in individual studies. In 11 RCTs, a 3-month course of NHT has been shown to improve pathological outcomes in most patients, but its effect on oncological outcomes is apparently limited.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024472
003      
CZ-PrNML
005      
20211013133917.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers13133274 $2 doi
035    __
$a (PubMed)34208888
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chan, Vinson Wai-Shun $u School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK $u S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China $u Division of Surgery and Interventional Science, University College London, London W1W 7TS, UK
245    10
$a Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer-A Systematic Review and Meta-Analysis / $c VW. Chan, WS. Tan, A. Asif, A. Ng, O. Gbolahan, E. Dinneen, W. To, H. Kadhim, M. Premchand, O. Burton, JS. Koe, N. Wang, JJ. Leow, G. Giannarini, N. Vasdev, SF. Shariat, D. Enikeev, CF. Ng, JY. Teoh
520    9_
$a External factors, such as the coronavirus disease 2019 (COVID-19), can lead to cancellations and backlogs of cancer surgeries. The effects of these delays are unclear. This study summarised the evidence surrounding expectant management, delay radical prostatectomy (RP), and neoadjuvant hormone therapy (NHT) compared to immediate RP. MEDLINE and EMBASE was searched for randomised controlled trials (RCTs) and non-randomised controlled studies pertaining to the review question. Risks of biases (RoB) were evaluated using the RoB 2.0 tool and the Newcastle-Ottawa Scale. A total of 57 studies were included. Meta-analysis of four RCTs found overall survival and cancer-specific survival were significantly worsened amongst intermediate-risk patients undergoing active monitoring, observation, or watchful waiting but not in low- and high-risk patients. Evidence from 33 observational studies comparing delayed RP and immediate RP is contradictory. However, conservative estimates of delays over 5 months, 4 months, and 30 days for low-risk, intermediate-risk, and high-risk patients, respectively, have been associated with significantly worse pathological and oncological outcomes in individual studies. In 11 RCTs, a 3-month course of NHT has been shown to improve pathological outcomes in most patients, but its effect on oncological outcomes is apparently limited.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Tan, Wei Shen $u Division of Surgery and Interventional Science, University College London, London W1W 7TS, UK $u Department of Urology, Royal Free Hospital, London NW3 2QG, UK
700    1_
$a Asif, Aqua $u Division of Surgery and Interventional Science, University College London, London W1W 7TS, UK $u Leicester Medical School, University of Leicester, Leicester LE1 7RH, UK
700    1_
$a Ng, Alexander $u UCL Medical School, University College London, London WC1E 6DE, UK
700    1_
$a Gbolahan, Olayinka $u Department of Urology, Royal Free Hospital, London NW3 2QG, UK
700    1_
$a Dinneen, Eoin $u Division of Surgery and Interventional Science, University College London, London W1W 7TS, UK
700    1_
$a To, Wilson $u Department of Urology, Royal Free Hospital, London NW3 2QG, UK
700    1_
$a Kadhim, Hassan $u Department of Urology, Ipswich Hospital, Ipswich IP4 5PD, UK
700    1_
$a Premchand, Melissa $u Department of Urology, Northwick Park Hospital, London HA1 3UJ, UK
700    1_
$a Burton, Oliver $u Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
700    1_
$a Koe, Jasmine Sze-Ern $u School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK
700    1_
$a Wang, Nicole $u UCL Medical School, University College London, London WC1E 6DE, UK
700    1_
$a Leow, Jeffrey J $u Department of Urology, Tan Tock Seng Hospital, Singapore 308433, Singapore
700    1_
$a Giannarini, Gianluca $u Urology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy
700    1_
$a Vasdev, Nikhil $u Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital Stevenage, School of Medicine and Life Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, 1090 Vienna, Austria $u Department of Urology, Comarcal Hospital, 17300 Monforte, Spain $u Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia $u Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA $u Department of Urology, Charles University, 116 36 Prague, Czech Republic
700    1_
$a Enikeev, Dmitry $u Institute for Urology and Reproductive Health, Sechenov University, 119991 Moscow, Russia
700    1_
$a Ng, Chi Fai $u S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
700    1_
$a Teoh, Jeremy Yuen-Chun $u S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 13, č. 13 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34208888 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013133914 $b ABA008
999    __
$a ind $b bmc $g 1708336 $s 1144969
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 13 $e 20210630 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Možnosti archivace